Dismissed
EB-2 NIW
EB-2 NIW Dismissed — Pharmaceutical Data Management (2024): did not establish the beneficiary's proposed endeavor has
Filing your own EB-2 NIW? See how your CV maps to the criteria this decision turned on — free strategy preview.
Decision Summary
The appeal was dismissed because the petitioner failed to establish that the beneficiary's proposed endeavor has national importance. The AAO concluded that while the work has merit for the employing pharmaceutical company, the evidence did not demonstrate a broader prospective impact on the U.S. data, pharmaceutical, or healthcare industry at a national level.
See how a decision like this gets cited in an EB-2 NIW petition →Criteria Discussed
Substantial Merit And National Importance Well Positioned To Advance The Proposed Endeavor Balance Of Factors Favors Waiver
📄 Original decision (USCIS PDF)
Sign up free to download the original PDF
Downloaded the case? Use it in your next draft →Filing your own EB-2 NIW? Learn from this denial.
Upload your CV and see how your profile maps to the criteria the AAO flagged here — free strategy preview, no credit card.
Map Your CV to These Criteria →No credit card required.